News Search Year - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 Archive October 6, 2016 Deciphera Pharmaceuticals Expands Board with Appointment of Two New Directors Archive August 1, 2016 Deciphera Pharmaceuticals to Present at the Canaccord Genuity 36th Annual Growth Conference Archive June 16, 2016 Deciphera Pharmaceuticals to Present at JMP Securities Life Sciences Conference Archive April 20, 2016 Deciphera’s Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor, DCC-3014, Demonstrates Potent Macrophage Checkpoint Inhibition as a Single Agent and In Combination with an Anti-PD1 Inhibitor Archive March 21, 2016 Deciphera Pharmaceuticals Announces Study Results for Altiratinib Demonstrating Inhibition of Tumor Growth and Invasiveness in Glioblastoma Archive March 17, 2016 Deciphera Pharmaceuticals to Present Data on its Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor, DCC-3014, at American Association for Cancer Research Annual Meeting 2016 Archive March 9, 2016 Deciphera Pharmaceuticals to Present at American Chemical Society Annual Meeting Archive February 29, 2016 Deciphera Pharmaceuticals to Present at Future Leaders in the Biotech Industry Conference Archive January 5, 2016 Deciphera Pharmaceuticals Increases Size of Series B Financing to over $90 Million with Addition of SV Life Sciences Archive December 1, 2015 Deciphera Pharmaceuticals to Present at Oppenheimer Annual Healthcare Conference
Archive October 6, 2016 Deciphera Pharmaceuticals Expands Board with Appointment of Two New Directors
Archive August 1, 2016 Deciphera Pharmaceuticals to Present at the Canaccord Genuity 36th Annual Growth Conference
Archive June 16, 2016 Deciphera Pharmaceuticals to Present at JMP Securities Life Sciences Conference
Archive April 20, 2016 Deciphera’s Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor, DCC-3014, Demonstrates Potent Macrophage Checkpoint Inhibition as a Single Agent and In Combination with an Anti-PD1 Inhibitor
Archive March 21, 2016 Deciphera Pharmaceuticals Announces Study Results for Altiratinib Demonstrating Inhibition of Tumor Growth and Invasiveness in Glioblastoma
Archive March 17, 2016 Deciphera Pharmaceuticals to Present Data on its Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor, DCC-3014, at American Association for Cancer Research Annual Meeting 2016
Archive March 9, 2016 Deciphera Pharmaceuticals to Present at American Chemical Society Annual Meeting
Archive February 29, 2016 Deciphera Pharmaceuticals to Present at Future Leaders in the Biotech Industry Conference
Archive January 5, 2016 Deciphera Pharmaceuticals Increases Size of Series B Financing to over $90 Million with Addition of SV Life Sciences
Archive December 1, 2015 Deciphera Pharmaceuticals to Present at Oppenheimer Annual Healthcare Conference
